NISHITH.TV
Mumbai
Silicon Valley
Bengaluru
Singapore
Mumbai BKC
New Delhi
New York
GIFT City
Locations
Mumbai
Silicon Valley
Bengaluru
Singapore
Mumbai BKC
New Delhi
New York
GIFT City
Research and Articles
Think Tanks
Research at NDA
Research Papers
Research Articles
Policy Papers
Hotline
Imaginarium Ali Gunjan (Global Research Campus)
Japan Desk ジャパンデスク
Hotline
Capital Markets Hotline
Climate Change Related Legal Issues
Companies Act Series
Competition Law Hotline
Corpsec Hotline
Court Corner
Cross Examination
Deal Destination
Debt Funding in India Series
Dispute Resolution Hotline
Education Sector Hotline
FEMA Hotline
Financial Service Update
Food & Beverages Hotline
Funds Hotline
Gaming Law Wrap
GIFT City Express
Green Hotline
HR Law Hotline
iCe Hotline
Insolvency and Bankruptcy Hotline
International Trade Hotlines
Investment Funds: Monthly Digest
IP Hotline
IP Lab
Legal Update
Let's Shape the Future of Law Together
Lit Corner
M&A Disputes Series
M&A Hotline
M&A Interactive
Media Hotline
New Publication
Other Hotline
Pharma & Healthcare Update
Press Release
Private Client Wrap
Private Debt Hotline
Private Equity Corner
Real Estate Update
Realty Check
Regulatory Digest
Regulatory Hotline
Renewable Corner
SEZ Hotline
Social Sector Hotline
Tax Hotline
Technology & Tax Series
Technology Law Analysis
Telecom Hotline
The Startups Series
White Collar and Investigations Practice
Yes, Governance Matters.
Japan Desk ジャパンデスク
Pharma & Healthcare Update
1
2
3
4
TITLE
DATE
Government contemplating to allow Phase I trials in India
08-09-2007
Mashelkar Committee submits its report on patentability of NCE's and micro-organisms
01-18-2007
Recent Mumbai High Court Rulings on Drug Regulations
05-11-2006
Guidelines for Medical Devices notified as "Drugs"
03-02-2006
New Bill to regulate scientific research on humans
12-15-2005
Destination India: Fastest growing Asian hub for clinical trials
10-14-2005
In Pipeline: New Drug policy
08-12-2005
Should Phase 1 Trials be permitted in India? - Debate continues
11-15-2003
First Exclusive Marketing Rights granted to Indian Pharmaceutical Company
09-25-2003